The effects of increasing body mass index on heartburn severity, frequency and response to treatment with dexlansoprazole or lansoprazole

BACKGROUND: Higher body mass index (BMI) is a recognised risk factor for gastro-oesophageal reflux disease (GERD). Data regarding the impact of BMI on proton pump inhibitor (PPI) therapy are conflicting. AIM: To assess the impact of BMI on baseline heartburn symptom severity and frequency and respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Peura, D A, Pilmer, B, Hunt, B, Mody, R, Perez, M C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Heartburn
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613742/
https://www.ncbi.nlm.nih.gov/pubmed/23451835
http://dx.doi.org/10.1111/apt.12270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613742/
https://www.ncbi.nlm.nih.gov/pubmed/23451835
http://dx.doi.org/10.1111/apt.12270

Ejemplares similares